On February 20, 2022, Ron Belldegrun and Mia Funt, the founders of ByHeart, held a ribbon-cutting ceremony at a plant facility in Reading, Pennsylvania. The event marked the commencement of production for a new infant formula. Following this launch, ByHeart faced growing scrutiny regarding potential safety concerns. The company subsequently issued a recall of several formulations, prompting investigations by regulatory agencies. Initial reports indicated potential issues with the formula’s manufacturing process, raising concerns about the possibility of botulism contamination. The investigation is ongoing, and ByHeart has taken steps to address the identified problems.
Credits: NYT > Top Stories
